Angioplasty versus stenting for superficial femoral artery lesions

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Twine, Christopher P ^a   Coulston, James ^b   Shandall, Ahmed ^a   McLain, Alexander D ^a  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b GREAT WESTERN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITINOL; TICLOPIDINE;

ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTERY OCCLUSION; CLINICAL TRIAL; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; QUALITY OF LIFE; REVIEW; STENT; SUPERFICIAL FEMORAL ARTERY; SYSTEMATIC REVIEW; WALKING;

EID: 70349110495     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006767.pub2     Document Type: Review

References (30)

1. Becquemin JP, Favre JP,Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. Journal of Vascular Surgery 2003;37(3):487-494 [PUBMED: 12618680] (Pubitemid 36350887)
2. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, et al.PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. Journal of Vascular and Interventional Radiology 2001;12(1):23-31. [PUBMED: 11200349] (Pubitemid 32097991)
3. Bosiers M, Peeters P, Krankenberg H. The Femoral Artery Stenting Trial (FAST): 12-month outcomes. Abstracts fromthe 2006Vascular Annual Meeting. 2006.
4. Krankenberg H. FAST: No advantage to nitinol stents in short lesions. TranscatheterCardiovascular TherapeuticsConference. 2006.
5. Krankenberg H. FAST (Femoral Artery Stenting Trial): Current evidence in femoral stenting: insights fromthe FAST trial Acute Results and 6-Month Outcomes. Leipzig Interventional Course; 2006 Jan 26-28, Leipzig. 2006.
6. Krankenberg H. Randomized comparison of PTA versus femoral artery stenting (FAST):Acute results. Journal of EndovascularTherapy 2005;12(Suppl 1):21-22
7. * Krankenberg H, SchluterM, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al.Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cmin length: the femoral artery stenting trial (FAST). Circulation 2007;116(3):285-292 [PUBMED: 17592075]
8. Grenacher L, Saam T, Geier A, Muller-Hulsbeck S, Cejna M, Kauffmann GW, et al.PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA) [PTA versus Stent bei Stenosen der A. femoralis und A. poplitea: Ergebnisse einer prospektiv randomisiertenMultizenterstudie (REFSA).]. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2004;176(9):1302-1310 [PUBMED: 15346266]
9. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, HellerM. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. Journal of Vascular and Interventional Radiology 2001;12(8):935-942 [PUBMED: 11487673] (Pubitemid 32756862)
10. Sabeti S, Czerwenka-Wenkstetten A, Dick P, Schlager O, Amighi J, Mlekusch I, et al.Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. Journal of Endovascular Therapy 2007;14(4):431-437 (Pubitemid 350154987)
11. Schillinger M, Sabeti S, Dick P, Amighi J, MlekuschW, Schlager O, et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115(21):2745-2749 (Pubitemid 46842791)
12. * Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New England Journal of Medicine 2006;354(18):1879- 1888 [PUBMED: 16672699]
13. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovascular and Interventional Radiology 1997;20 (6):420-425 [PUBMED: 9354709] (Pubitemid 27512031)
14. ZdanowskiZ,AlbrechtssonU, LundinA, JonungT, RibbeE, Thorne J, et al.Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. International Angiology 1999;18(4):251-255 [PUBMED: 10811511]
15. Ahn S, Rutherford RB. A multicenter prospective randomized trial to determine the optimal treatment of patients with claudication and isolated superficial femoral artery occlusive disease: conservative versus endovascular versus surgical therapy. Journal of Vascular Surgery 1992;15(5):889-891 [PUBMED: 1533686]
16. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et al.Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. Journal of Endovascular Therapy : Official Journal of the International Society of Endovascular Specialists 2006;13(6):701-710 [PUBMED: 17154704] (Pubitemid 44907633)
17. Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. Journal of vascular and interventional radiology : JVIR 2003;14(3):303-311 [PUBMED: 12631634] (Pubitemid 36314758)
18. Anonymous. Intracoil® Self-Expanding Peripheral Stent PO000033. http://www.fda.gov/cdrh/pdf/P000033b.pdf 2001:1-13.
19. Greenberg D, Rosenfield K,Garcia LA, BerezinRH, LavelleT, Fogleman S, et al.In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). Journal of Vascular and Interventional Radiology 2004;15(10):1065-1069 [PUBMED: 15466792] (Pubitemid 39346686)
20. Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, et al.The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical PracticeGuidelines (8th Edition). Chest 2008;133(6 Suppl):776S-814S. [PUBMED: 18574278] (Pubitemid 351894917)
21. Fontaine VR, Kim M, Kienny R. Surgical treatment for peripheral vascular disease [Die chirurgischeBehandlung der peripherenDurchblutungsstorungen]. Helvetica Chirurgica Acta 1954;5/6:499-533.
22. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. International Journal of Epidemiology 1991;20(2):384-392
23. Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al.Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cmin length: the femoral artery stenting trial (FAST). Circulation 2007;116(3):285-292 [PUBMED: 17592075] (Pubitemid 47196564)
24. Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis. Journal of Vascular Surgery 2008;47(2):461-469 [PUBMED: 17950563] (Pubitemid 351172652)
25. Norgren L,Hiatt WR,Dormany JA,NehlerMR,Harris KA, Fowkes FG, et al.Inter-Society consensus for the Management of Peripheral ArterialDisease (TASCII). European Journal of Vascular and Endovascular Surgery 2007;33(Suppl 1):S1-75.
26. Sabeti S, Czerwenka-Wenkstetten A, Dick P, Schlager O, Amighi J, Mlekusch I, et al.Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. Journal of EndovascularTherapy: Official Journal of the International Society of Endovascular Specialists 2007;14 (4):431-437 [PUBMED: 17696615] (Pubitemid 350154987)
27. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New England Journal of Medicine 2006;354(18):1879-1888 [PUBMED: 16672699] (Pubitemid 43872689)
28. Schillinger M, Sabeti S, Dick P, Amighi J, MlekuschW, Schlager O, et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115(21):2745-2749 [PUBMED: 17502568] (Pubitemid 46842791)
29. Selvin E, Erlinger TP. Prevelance of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004;110(6):738-743
30. ZdanowskiZ,AlbrechtssonU, LundinA, JonungT, RibbeE, Thorne J, et al.Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomised controlled study. International Angiology 1999;18(4):251-5. * Indicates the major publication for the study